by Artificial Intelligence Expert
Changing the Future for Your Health
Our mission is to revolutionize early cancer detection using Generative AI for biomedical data analysis.
At AIMedExpert, a brand of Artificial Intelligence Expert Company (AIE), we are committed to transforming cancer care through groundbreaking AI-driven early detection. Our innovative non-invasive tests can identify 32 types of cancer with over 99-100% accuracy, offering a profound impact by alleviating fear, pain, and financial burdens for patients. Since 2008, our collaboration with the renowned MD Anderson Cancer Center has yielded remarkable breakthroughs in oncology diagnostics. Achieving near-perfect accuracy, our innovations have secured international patents, setting new benchmarks in the industry.
Alexandru Floares, MD,PhD
CEO and Founder
Alexandru Floares, MD, PhD, founder and CEO of Artificial Intelligence Expert, is a leader in AI-powered medical diagnostics and therapy personalization. Since founding the AI Department at the Oncology Institute of Cluj-Napoca in 2000 and launching SAIA in 2004, he has set new industry standards, particularly in oncology. His work includes developing the first intelligent system for extracting mathematical models from biomedical data and leading significant research projects. Dr. Floares has presented his findings at prestigious institutions such as the NIH and the Vatican, published extensively, and received numerous awards. Since 2008, his collaboration with MD Anderson Cancer Center has led to revolutionary AI-enabled diagnostics for various cancers, achieving up to 100% accuracy and resulting in an international patent application.
Our team is led by our CEO, recognized as one of the 500 geniuses of the 21st century, with vast expertise in AI and medicine. We also have young, ambitious bioinformaticians and researchers specialized in multidisciplinary fields. Their combined talents drive our innovative approach to early cancer detection and revolutionizing research through the implementation of AI tools for researchers.
Our Team
Carmen Floares
CoFounder & Chief Medical Officer
Catalin Marginean
Account & Financial Manager
Adrian Zety
Chief Technology Officer
Lampros Androutsos
Product Manager
Larisa Petcu
Project Manager
Advisory Board
Our Advisory Board includes world-renowned cancer research and computing professors, as well as experienced leaders in business development and marketing. Their combined expertise drives our mission to revolutionize early cancer detection with advanced AI technologies.
George Calin,
MD-PhD
Co-Director of The RNA Interference and Non-coding RNA Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Florin Manolache, PhD
Director of Scientific Computing for MCS at Carnegie Mellon University
Antonio Ornelas-Soares, PhD
CEO of LUMABS
Ada Brzezicki,
MD, MBA
Senior Business Development Manager at Partner International
Mihaela Rus
CEO Vitrina Advertising